We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IPCI market cap is 2.65M. The company's latest EPS is USD -0.0874 and P/E is -0.92.
| Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.71M | 3.48M | 1.4M | 0 | 66k |
| Operating Income | -13.33M | -7.84M | -4.68M | -4.69M | -2.85M |
| Net Income | -13.75M | -8.09M | -3.39M | -5.15M | -2.89M |
| Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.47M | 3.8M | 3.39M | 2.1M | 1.43M |
| Total Liabilities | 7.37M | 7.49M | 9.7M | 10.25M | 12.01M |
| Total Equity | 4.1M | -3.69M | -6.31M | -8.16M | -10.58M |
| Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.51M | -6.66M | 112k | -2.46M | -1.39M |
| Investing | -101k | -14k | 25k | N/A | 500k |
| Financing | 17.35M | 101k | N/A | 3.03M | 200k |
| Market Cap | 2.65M |
| Price to Earnings Ratio | -0.92 |
| Price to Sales Ratio | 40 |
| Price to Cash Ratio | 32 |
| Price to Book Ratio | -0.25 |
| Dividend Yield | - |
| Shares Outstanding | 33.09M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 14.29% |
| 52 Week High | 0.135 |
| 52 Week Low | 0.055 |
| Spread (Intraday) | 0.05 (41.67%) |
| Company Name | IntelliPharmaCeutics International Inc |
| Address |
30 worcester road toronto, ontario M9W 5X2 |
| Website | https://www.intellipharmaceutics.com |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
